SiNON Nano Sciences assets are based on cutting-edge Carbon Nano Particles(CNP) technology, which forms the basis of our innovative products aimed at improving drug delivery systems and therapeutic outcomes.

Versatility: Our CNPs are engineered to conjugate with various compounds, enhancing their functionality and application across different therapeutic areas. 
Targeted Delivery: By conjugating CNPs with molecules like Arginine Peptide, we can achieve precise targeting, reducing side effects and increasing treatment efficacy.
Enhanced Drug Encapsulation: Our CNP-based formulations are designed to encapsulate drug, improving their stability and controlled release.